Non-papillary superficial duodenal tumor
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)The patient has a lesion diagnosed as a superficial tumor (adenoma or intramucosal carcinoma) of the non-papillary part of the duodenum by endoscopy and is scheduled for CSP or ESD. (2) The lesion is located in the bulb, descending part, or horizontal part of the duodenum, and there is no continuity with the papilla. (3) In case of multiple lesions, the maximum number of lesions to be treated is 10. (4) The patient's age at the time of enrollment should be 20 years or older. (5) The patient has been fully informed about the participation in the study and has given his/her consent.
Exclusion criteria
Exclusion criteria: (1) In accordance with the "Guidelines for Gastrointestinal Endoscopy for Patients Taking Antithrombotic Drugs (2017 Supplement on Anticoagulants)", temporary discontinuation of antithrombotic medication is not possible and endoscopic treatment cannot be performed (discontinuation of medication is not mandatory if endoscopic treatment is possible). (2) Patients with infections that require systemic treatment (3) Pregnant or lactating women (4) Patients for whom follow-up after 4 weeks is not possible (5) Patients who are judged inappropriate by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemostasis rate of bleeding during duodenal CSP and ESD using Self-assembling peptide | — |
Countries
Japan
Contacts
Kyoto Prefectural University of Medicine Gastroenterology